Product Information
ENTECAVIR 0.5 MG TABLET is a generic product labeled by Solco Healthcare US LLC, priced at $0.2117 per EA under NDC 43547043603. Its NADAC has been published 409 times since Aug 29, 2018.
Strength
.5 mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547043603
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ENTECAVIR ANHYDROUSApproval Type
Generic (ANDA)
FDA Application
ANDA208782On Market Since
4/1/2018
Pharmacological Classes
Price Statistics
The NADAC for ENTECAVIR 0.5 MG TABLET has been published 409 times since Aug 29, 2018, and over the history we have for it it has declined 91.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2117 per EA |
|---|---|
| All-time high | $2.7071 (Nov 14, 2018) |
| All-time low | $0.2096 (May 20, 2026) |
| 52-week high | $0.2677 |
| 52-week low | $0.2096 |
| Median price | $0.7313 |
| Average price | $0.8855 |
| Largest weekly change | +48.1% (Jul 17, 2024) |
| Weeks tracked | 409 |
| Tracking since | Aug 29, 2018 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ENTECAVIR 0.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ENTECAVIR 0.5 MG TABLET, manufactured by Solco Healthcare US LLC, is $0.2117 per EA (NDC 43547043603), effective Jun 24, 2026.
How has the price of ENTECAVIR 0.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for ENTECAVIR 0.5 MG TABLET has declined 91.0%. It has been tracked across 409 weekly CMS publications since Aug 29, 2018.
What are the highest and lowest recorded NADAC prices for ENTECAVIR 0.5 MG TABLET?
Since Aug 29, 2018, the NADAC for ENTECAVIR 0.5 MG TABLET has ranged from a low of $0.2096 (May 20, 2026) to a high of $2.7071 (Nov 14, 2018), with a median of $0.7313 per EA.
Are there cheaper alternatives to ENTECAVIR 0.5 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as ENTECAVIR 0.5 MG TABLET, but none are currently priced below it.
Who manufactures ENTECAVIR 0.5 MG TABLET?
ENTECAVIR 0.5 MG TABLET (NDC 43547043603) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification